Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 26.02 BRL 2.56% Market Closed
Market Cap: 44.6B BRL
Have any thoughts about
Raia Drogasil SA?
Write Note

Raia Drogasil SA
Unrealized Security Profit/Loss

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Raia Drogasil SA
Unrealized Security Profit/Loss Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Unrealized Security Profit/Loss CAGR 3Y CAGR 5Y CAGR 10Y
Raia Drogasil SA
BOVESPA:RADL3
Unrealized Security Profit/Loss
R$73.8m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
19%
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
d
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Raia Drogasil SA
Glance View

Market Cap
44.6B BRL
Industry
Retail

Raia Drogasil SA is a leading retail pharmacy chain in Brazil, established through the merger of two prominent companies, Raia and Drogasil, creating a powerhouse in the pharmaceutical and personal care sectors. With a mission to cater to the healthcare and wellness needs of Brazilians, the company operates over 2,300 stores across key urban regions, boasting a comprehensive product range that includes prescription medications, over-the-counter drugs, beauty products, and health-related services. Investors are drawn to Raia Drogasil for its strong market position, supported by a consistent strategy of expansion, innovation, and a commitment to customer service, making it a trusted name in the fast-growing Brazilian pharmaceutical market. In recent years, Raia Drogasil has implemented advanced sales and inventory management systems to enhance operational efficiency and customer satisfaction. The company's focus on growth is further reinforced by a robust online presence, enabling it to capture emerging e-commerce trends among Brazilian consumers. With a resilient business model, anchored by a broad geographic footprint and an increasingly diverse product offering, Raia Drogasil stands poised for long-term success. As Brazil's middle class continues to expand and healthcare spending rises, the company presents a compelling opportunity for investors looking to tap into a thriving market with promising growth potential.

RADL3 Intrinsic Value
20.8 BRL
Overvaluation 20%
Intrinsic Value
Price

See Also

What is Raia Drogasil SA's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
73.8m BRL

Based on the financial report for Sep 30, 2024, Raia Drogasil SA's Unrealized Security Profit/Loss amounts to 73.8m BRL.

What is Raia Drogasil SA's Unrealized Security Profit/Loss growth rate?
Unrealized Security Profit/Loss CAGR 10Y
19%

Over the last year, the Unrealized Security Profit/Loss growth was 409%. The average annual Unrealized Security Profit/Loss growth rates for Raia Drogasil SA have been 69% over the past three years , and 19% over the past ten years .

Back to Top